• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

针对伴有突变的伦诺克斯-加斯托综合征的奎尼丁治疗。病例报告及文献综述。

Quinidine Therapy for Lennox-Gastaut Syndrome With Mutation. A Case Report and Literature Review.

作者信息

Jia Yu, Lin Yicong, Li Jing, Li Mingyu, Zhang Yifan, Hou Yue, Liu Aihua, Zhang Liping, Li Liping, Xiang Peng, Ye Jing, Huang Zhaoyang, Wang Yuping

机构信息

Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China.

Beijing Key Laboratory of Neuromodulation, Beijing, China.

出版信息

Front Neurol. 2019 Feb 5;10:64. doi: 10.3389/fneur.2019.00064. eCollection 2019.

DOI:10.3389/fneur.2019.00064
PMID:30804880
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6370615/
Abstract

Mutations in the Potassium channel subfamily T member 1 () gene have been reported in a range of epileptic encephalopathies. Here we report the case of a 12-year-old male suffering from multiple types of epileptic seizures and cognitive decline from the age of 10. The patient had four types of epileptic seizures, including tonic seizures, atypical absence seizures, myoclonic seizures, and generalized tonic-clonic seizures. The electroencephalogram showed generalized slow spike-and-slow-waves, mutiple-spike-and-slow-waves, as well as short-term fast rhythms bursts. Thus, he was diagnosed with Lennox-Gastaut syndrome. The patient had failed to control seizures after using five first-line antiepileptic drugs. Whole exome sequencing revealed a missense mutation (c.625 C>T). Previous studies revealed that quinidine could block the channel. Therefore, we assumed that quinidine might be effective for him. Add-on treatment with quinidine was started when the patient was 12 years old. After an 8-month treatment, the frequency of seizures and epileptiform discharges were significantly reduced. In conclusion, quinidine therapy may offer a new choice for the treatment of Lennox-Gastaut syndrome with mutations.

摘要

钾通道亚家族T成员1()基因突变已在一系列癫痫性脑病中被报道。在此,我们报告一例12岁男性病例,该患者自10岁起就患有多种类型的癫痫发作并伴有认知功能减退。患者有四种类型的癫痫发作,包括强直发作、非典型失神发作、肌阵挛发作和全身强直阵挛发作。脑电图显示广泛性慢棘慢波、多棘慢波以及短期快速节律暴发。因此,他被诊断为Lennox-Gastaut综合征。该患者在使用五种一线抗癫痫药物后仍未能控制癫痫发作。全外显子测序发现一个错义突变(c.625 C>T)。既往研究表明奎尼丁可阻断通道。因此,我们推测奎尼丁可能对他有效。该患者12岁时开始加用奎尼丁治疗。经过8个月的治疗,癫痫发作频率和癫痫样放电明显减少。总之,奎尼丁治疗可能为伴有突变的Lennox-Gastaut综合征的治疗提供一种新的选择。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14b0/6370615/5da8ee406ff9/fneur-10-00064-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14b0/6370615/9ba59107c8ad/fneur-10-00064-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14b0/6370615/5da8ee406ff9/fneur-10-00064-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14b0/6370615/9ba59107c8ad/fneur-10-00064-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14b0/6370615/5da8ee406ff9/fneur-10-00064-g0002.jpg

相似文献

1
Quinidine Therapy for Lennox-Gastaut Syndrome With Mutation. A Case Report and Literature Review.针对伴有突变的伦诺克斯-加斯托综合征的奎尼丁治疗。病例报告及文献综述。
Front Neurol. 2019 Feb 5;10:64. doi: 10.3389/fneur.2019.00064. eCollection 2019.
2
Quinidine therapy for West syndrome with KCNTI mutation: A case report.伴有KCNTI突变的韦斯特综合征的奎尼丁治疗:一例报告
Brain Dev. 2017 Jan;39(1):80-83. doi: 10.1016/j.braindev.2016.08.002. Epub 2016 Aug 28.
3
KCNT1-positive epilepsy of infancy with migrating focal seizures successfully treated with nonnarcotic antitussive drugs after treatment failure with quinidine: A case report.婴儿期伴有游走性局灶性发作的 KCNT1 阳性癫痫,奎尼丁治疗失败后改用非麻醉性镇咳药治疗成功:病例报告。
Brain Dev. 2020 Sep;42(8):607-611. doi: 10.1016/j.braindev.2020.05.002. Epub 2020 Jun 3.
4
KCNT1-related epilepsies and epileptic encephalopathies: phenotypic and mutational spectrum.KCNT1 相关性癫痫和癫痫性脑病:表型和突变谱。
Brain. 2021 Dec 31;144(12):3635-3650. doi: 10.1093/brain/awab219.
5
Epileptiform EEG activity of the centromedian thalamic nuclei in children with intractable generalized seizures of the Lennox-Gastaut syndrome.Lennox-Gastaut综合征难治性全身性癫痫患儿丘脑中央中核的癫痫样脑电图活动
Epilepsia. 1991 May-Jun;32(3):310-21. doi: 10.1111/j.1528-1157.1991.tb04657.x.
6
Children With Trisomy 21 and Lennox-Gastaut Syndrome With Predominant Myoclonic Seizures.唐氏综合征并 Lennox-Gastaut 综合征患儿,以肌阵挛性癫痫发作为主。
J Child Neurol. 2021 Oct;36(11):1027-1033. doi: 10.1177/08830738211026072. Epub 2021 Jul 27.
7
Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures.拉莫三嗪辅助治疗儿童和青少年原发性全面性强直阵挛发作。
Pediatrics. 2006 Aug;118(2):e371-8. doi: 10.1542/peds.2006-0148. Epub 2006 Jul 17.
8
Early Treatment with Quinidine in 2 Patients with Epilepsy of Infancy with Migrating Focal Seizures (EIMFS) Due to Gain-of-Function KCNT1 Mutations: Functional Studies, Clinical Responses, and Critical Issues for Personalized Therapy.两名婴儿癫痫伴局灶性阵挛发作(EIMFS)因 KCNT1 功能获得性突变所致,早期应用奎尼丁治疗:功能研究、临床反应及个体化治疗的关键问题。
Neurotherapeutics. 2018 Oct;15(4):1112-1126. doi: 10.1007/s13311-018-0657-9.
9
GABA receptor β3 subunit mutation D120N causes Lennox-Gastaut syndrome in knock-in mice.γ-氨基丁酸(GABA)受体β3亚基突变D120N在基因敲入小鼠中引发Lennox-Gastaut综合征。
Brain Commun. 2020;2(1):fcaa028. doi: 10.1093/braincomms/fcaa028. Epub 2020 Mar 10.
10
Delineation of cryptogenic Lennox-Gastaut syndrome and myoclonic astatic epilepsy using multiple correspondence analysis.使用多重对应分析对隐源性Lennox-Gastaut综合征和肌阵挛失张力癫痫进行描述。
Epilepsy Res. 1999 Aug;36(1):15-29. doi: 10.1016/s0920-1211(99)00021-2.

引用本文的文献

1
KCNT1 gene variant-associated epilepsy: genetic insights, functional mechanisms, and emerging therapies.KCNT1基因变异相关癫痫:遗传学见解、功能机制及新兴疗法
J Neurol. 2025 Jun 21;272(7):472. doi: 10.1007/s00415-025-13207-9.
2
Nontraditional Antiseizure Medications to Consider When Traditional Options Have Failed: Medications for Refractory Seizures and Epilepsies.传统治疗方案无效时可考虑的非传统抗癫痫药物:难治性癫痫发作和癫痫的治疗药物
J Pediatr Pharmacol Ther. 2025 Jun;30(3):306-322. doi: 10.5863/JPPT-25-01203. Epub 2025 Jun 9.
3
Precision Therapeutics in Lennox-Gastaut Syndrome: Targeting Molecular Pathophysiology in a Developmental and Epileptic Encephalopathy.

本文引用的文献

1
Early Treatment with Quinidine in 2 Patients with Epilepsy of Infancy with Migrating Focal Seizures (EIMFS) Due to Gain-of-Function KCNT1 Mutations: Functional Studies, Clinical Responses, and Critical Issues for Personalized Therapy.两名婴儿癫痫伴局灶性阵挛发作(EIMFS)因 KCNT1 功能获得性突变所致,早期应用奎尼丁治疗:功能研究、临床反应及个体化治疗的关键问题。
Neurotherapeutics. 2018 Oct;15(4):1112-1126. doi: 10.1007/s13311-018-0657-9.
2
Does age affect response to quinidine in patients with KCNT1 mutations? Report of three new cases and review of the literature.年龄是否会影响携带KCNT1突变患者对奎尼丁的反应?三例新病例报告及文献综述。
Seizure. 2018 Feb;55:1-3. doi: 10.1016/j.seizure.2017.11.017. Epub 2017 Dec 23.
3
伦诺克斯-加斯托综合征的精准治疗:针对发育性和癫痫性脑病的分子病理生理学
Children (Basel). 2025 Apr 8;12(4):481. doi: 10.3390/children12040481.
4
Electrophysiological characterization of human KCNT1 channel modulators and the therapeutic potential of hydroquinine and tipepidine in KCNT1 mutation-associated epilepsy mouse model.人类KCNT1通道调节剂的电生理特性以及对苯二酚和替哌啶在KCNT1突变相关癫痫小鼠模型中的治疗潜力
Acta Pharmacol Sin. 2025 May;46(5):1190-1204. doi: 10.1038/s41401-024-01457-8. Epub 2025 Jan 27.
5
Structure-Activity Relationship Studies in a Series of 2-Aryloxy--(pyrimidin-5-yl)acetamide Inhibitors of SLACK Potassium Channels.一系列2-芳氧基--(嘧啶-5-基)乙酰胺类SLACK钾通道抑制剂的构效关系研究
Molecules. 2024 Nov 21;29(23):5494. doi: 10.3390/molecules29235494.
6
Clinical trials for Lennox-Gastaut syndrome: Challenges and priorities.Lennox-Gastaut 综合征的临床试验:挑战与重点。
Ann Clin Transl Neurol. 2024 Nov;11(11):2818-2835. doi: 10.1002/acn3.52211. Epub 2024 Oct 23.
7
Structure-Activity Relationship Studies in a Series of Xanthine Inhibitors of SLACK Potassium Channels.一系列 SLACK 钾通道黄嘌呤抑制剂的构效关系研究。
Molecules. 2024 May 22;29(11):2437. doi: 10.3390/molecules29112437.
8
Design, synthesis, and biological evaluation of a novel series of 1,2,4-oxadiazole inhibitors of SLACK potassium channels: Identification of in vitro tool VU0935685.新型 SLACK 钾通道 1,2,4-恶二唑抑制剂的设计、合成及生物学评价:体外工具 VU0935685 的鉴定。
Bioorg Med Chem. 2023 Nov 15;95:117487. doi: 10.1016/j.bmc.2023.117487. Epub 2023 Sep 30.
9
New use for an old drug: quinidine in KCNT1-related epilepsy therapy.一种老药的新用途:奎尼丁用于治疗与KCNT1相关的癫痫
Neurol Sci. 2023 Apr;44(4):1201-1206. doi: 10.1007/s10072-022-06521-x. Epub 2022 Nov 28.
10
Structure-activity relationship studies in a new series of 2-amino-N-phenylacetamide inhibitors of Slack potassium channels.新型 2-氨基-N-苯乙酰胺 Slack 钾通道抑制剂的构效关系研究。
Bioorg Med Chem Lett. 2022 Nov 15;76:129013. doi: 10.1016/j.bmcl.2022.129013. Epub 2022 Sep 29.
Clinical and molecular characterization of -related severe early-onset epilepsy.
- 相关严重早发性癫痫的临床和分子特征。
Neurology. 2018 Jan 2;90(1):e55-e66. doi: 10.1212/WNL.0000000000004762. Epub 2017 Dec 1.
4
Precision therapy for epilepsy due to mutations: A randomized trial of oral quinidine.致 突变相关癫痫的精准治疗:口服奎尼丁的随机试验。
Neurology. 2018 Jan 2;90(1):e67-e72. doi: 10.1212/WNL.0000000000004769. Epub 2017 Dec 1.
5
A quinidine non responsive novel KCNT1 mutation in an Indian infant with epilepsy of infancy with migrating focal seizures.一名患有婴儿期迁移性局灶性癫痫发作的印度婴儿中一种对奎尼丁无反应的新型KCNT1突变。
Brain Dev. 2018 Mar;40(3):229-232. doi: 10.1016/j.braindev.2017.09.008. Epub 2017 Oct 14.
6
[Clinical features and gene mutations in epilepsy of infancy with migrating focal seizures].[婴儿游走性局灶性癫痫发作的临床特征及基因突变]
Zhonghua Er Ke Za Zhi. 2016 Oct 2;54(10):735-739. doi: 10.3760/cma.j.issn.0578-1310.2016.10.005.
7
Quinidine therapy for West syndrome with KCNTI mutation: A case report.伴有KCNTI突变的韦斯特综合征的奎尼丁治疗:一例报告
Brain Dev. 2017 Jan;39(1):80-83. doi: 10.1016/j.braindev.2016.08.002. Epub 2016 Aug 28.
8
Ineffective quinidine therapy in early onset epileptic encephalopathy with KCNT1 mutation.KCNT1突变所致早发性癫痫性脑病中奎尼丁治疗无效
Ann Neurol. 2016 Mar;79(3):502-3. doi: 10.1002/ana.24598. Epub 2016 Feb 12.
9
Quinidine in the treatment of KCNT1-positive epilepsies.奎尼丁治疗KCNT1阳性癫痫
Ann Neurol. 2015 Dec;78(6):995-9. doi: 10.1002/ana.24520. Epub 2015 Nov 18.
10
Mutations in KCNT1 cause a spectrum of focal epilepsies.KCNT1基因的突变会引发一系列局灶性癫痫。
Epilepsia. 2015 Sep;56(9):e114-20. doi: 10.1111/epi.13071. Epub 2015 Jun 30.